OASL

OASL

Target · Antiviral protein

OASL 2'-5'-oligoadenylate synthetase like · 2'-5'-oligoadenylate synthase-like protein

OASL (2'-5'-oligoadenylate synthetase like, also known as TRIP14, p59OASL and OASL1) is a member of the 2-5A synthase family that binds double-stranded RNA and restricts viral replication. Unlike its relatives, it has no 2'-5'-OAS activity. Browse Assay Genie's current range of OASL research reagents below, or read on for the biology behind the target.

Nucleolus and cytoplasmBinds double-stranded RNARNase L-independent antiviral
514 aa
Protein length
~59 kDa
Molecular weight
12q24.31
Gene locus
2-5A synthase
Protein family
Target information

What is OASL (2'-5'-oligoadenylate synthetase like)?

OASL belongs to the 2-5A synthase family, but it does not have 2'-5'-OAS activity. It can still bind double-stranded RNA, and the NCBI Gene summary also lists DNA binding activity. This sets it apart from classical family members that synthesise 2'-5'-linked oligoadenylates.

Functionally, OASL displays antiviral activity against encephalomyocarditis virus (EMCV) and hepatitis C virus (HCV). It acts through an alternative antiviral pathway that is independent of RNase L. Gene annotation links the protein to negative regulation of viral genome replication and to positive regulation of RIG-I signalling, as well as to the interleukin-27-mediated signalling pathway.

The OASL protein is located in the nucleolus and the cytoplasm (cytosol). The gene is listed by HGNC within the 2'-5'-oligoadenylate synthetase family and has also been named TRIP14, p59OASL and OASL1. A rat ortholog, Oasl, is recorded in the data supplied. Researchers studying OASL often work on innate antiviral responses, double-stranded RNA sensing and RIG-I pathway regulation, using tools such as an OASL antibody or an OASL ELISA kit to examine expression of the OASL gene and protein.

Antiviral innate immunity

OASL shows antiviral activity against EMCV and HCV through a pathway independent of RNase L, making it a useful subject for studying alternative interferon-linked defences.

Viral replication control

Annotated as a negative regulator of viral genome replication, OASL is studied for how host proteins limit the replication of RNA viruses.

RIG-I signalling

OASL is involved in positive regulation of the RIG-I signalling pathway, linking it to cytosolic RNA sensing and downstream antiviral responses.

Double-stranded RNA binding

Although it lacks 2'-5'-OAS activity, OASL binds double-stranded RNA, offering a model for how catalytically inactive family members retain function.

Background

OASL frequently asked questions

What does OASL do?

OASL binds double-stranded RNA but has no 2'-5'-OAS activity. It displays antiviral activity against encephalomyocarditis virus and hepatitis C virus through an alternative pathway independent of RNase L. It is also annotated as a positive regulator of RIG-I signalling and a negative regulator of viral genome replication.

What other names does OASL go by?

OASL is the HGNC symbol for 2'-5'-oligoadenylate synthetase like. UniProt names the product 2'-5'-oligoadenylate synthase-like protein. Aliases and previous symbols include TRIP14, p59OASL and OASL1. The protein belongs to the 2-5A synthase family, also called the 2'-5'-oligoadenylate synthetase family.

Is OASL conserved in other species?

The data list a rat ortholog, Oasl, while the mouse ortholog is recorded as unknown in this dataset. Species relationships should be confirmed against current databases, and you should check the datasheet of any product for its validated reactivity.

Explore

Related targets

Other 2'-5'-oligoadenylate synthetases, RNase L, RIG-I and interleukin-27 signalling targets relevant to antiviral research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q15646; product specifications from Assay Genie datasheets.

OASL Product listing